Substance use profile among the first episode and clinical high-risk patients in South-West Finland
708.18 KB
suljettu
Julkaisu on tekijänoikeussäännösten alainen. Teosta voi lukea ja tulostaa henkilökohtaista käyttöä varten. Käyttö kaupallisiin tarkoituksiin on kielletty.
Lataukset43
Pysyvä osoite
Verkkojulkaisu
DOI
Tiivistelmä
The aim of this study was to evaluate prevalence of substance use among first-episode psychosis (FEP) and clinical high-risk (CHR) patients in the hospital district of Southwest Finland, compared to the general population. The sample (n = 356) included in- and outpatients from the psychiatric clinics of the City of Turku and the Hospital district of Southwest Finland. Information concerning self-reported cigarette smoking, alcohol, cannabis and other illicit drug use was collected using questionnaires.
In the FEP group, current use of tobacco (OR: 9.2, 95% CI: 3.4-24.9, p < 0.001), cannabis use during lifetime (OR: 2, 95 % CI: 1.2-3.4, p = 0.013) and past 12 months (OR: 2.3, 95 % CI: 1.3-4.3, p-value = 0.007) as well as other illicit drug use during lifetime (OR: 5.1, 95 % CI: 2.6-10.2, p-value < 0.001) and past 12 months (OR: 8, 95 % CI: 3-21.7, p-value < 0.001) was found to be significantly more prevalent than among general population controls. Respectively in the CHR group, use of tobacco (OR: 3.4, 95% CI: 1.1-10.9, p = 0.036) and other illicit drugs both during lifetime (OR: 4, 95 % CI: 1.8-9, p-value = 0.001) and past 12 months (OR: 4.8, 95 % CI: 1.5-15.2, p-value = 0.008) was more common compared to the general population. Risk-level alcohol use wasn’t more prevalent among either patient group.
Our study shows that especially cigarette smoking and illicit drug use was more common among both the first-episode psychosis and clinical high-risk patients compared to the general population controls.